• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ambalal Sarabhai Enterprises Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Sarabhai Ent
  • BSE Code : 14.0
  • ISIN : INE432A01017
32.88 -2 (-5.05%)
  • As on 27 Jul 2025 (EOD)

  • Today’s Low

    32.53

  • Today’s High

    34.99

  • Open

    34.75

  • Perv Close

    34.63

  • 52W Low

    32.53

  • 52W High

    73.95

Key Indicators

  • P/E(TTM)

    84.31

  • Mar.Cap (₹Cr.)

    251.97

  • Div & Yield %

    0.00

  • Book Value(₹)

    6.33

  • Debt-Equity Ratio

    -5.05

  • AGM Date

    25-Jul-2025

  • EPS

    0.39

  • P/E Ratio

    84.31

Financials Ratios

  • Debt-Equity Ratio

    0.34

  • Mar.Cap (₹Cr.)

    251.97

  • RONW (%)

    3.98

  • ROCE (%)

    6.73

Score Board

  • Equity (₹ in Cr.)

    76.63

  • BV (₹)

    6.30

  • Sales( ₹ in Cr.)

    4.04

  • NP (in Cr.)

    3.02

  • NP Var(%)

    17.0

  • Div%

    0.0

  • CPS (₹)

    0.40

  • EPS (₹)

    0.40

  • Traded Value (₹ in Lakhs)

    251.97

  • 52 Week High

    73.95

  • 52 Week Low

    32.53

  • Price BSE

    33.0

  • Price NSE

    4.00

  • Market Capital( in Cr.)

    251.97

  • P/C Ratio

    81.10

  • P/E Ratio

    83.80

  • Price Vs.BV

    0.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 4.04 3.81 3.71 0.13 0.00 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 4.04 3.81 3.71 0.13 0.00 0.00
Other Income 20.50 7.89 18.66 39.54 29.61 24.61
Stock Adjustments 0.00 0.00 0.02 0.00 0.00 0.00
Total Income 24.54 11.70 22.39 39.67 29.61 24.61
EXPENDITURE :            
Raw Materials 3.95 3.71 3.65 0.12 0.00 0.00
Power and Fuel Cost 0.06 0.10 0.10 0.07 0.11 0.08
Employee Cost 0.87 2.04 2.21 2.51 3.26 3.35
Other Manufacturing Expenses 0.36 0.35 0.31 0.35 0.70 0.18
Selling and Administration Expenses 4.00 1.88 2.19 2.04 3.03 3.46
Miscellaneous Expenses 6.77 0.53 9.34 30.68 31.05 0.78
Employee Benefit Expenses 0.87 2.04 2.21 2.51 3.26 3.35
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 16.01 8.62 17.80 35.77 38.14 7.85
Operating Profit 8.52 3.09 4.59 3.89 -8.53 16.75
Interest 0.34 2.16 0.11 0.25 0.56 0.46
Gross Profit 8.18 0.93 4.48 3.64 -9.09 16.29
Depreciation 0.10 0.12 0.15 0.19 0.38 0.39
Profit Before Tax 8.08 0.81 4.33 3.45 -9.47 15.90
Current Tax 0.00 -2.15 0.00 -0.25 0.21 0.04
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.16 0.39 0.23 0.75 -0.29 0.31
Reported Net Profit 8.24 2.58 4.11 2.96 -9.39 15.55
Extraordinary Items 5.22 0.00 -0.69 -0.43 -6.76 0.28
Adjusted Net Profit 3.02 2.58 4.80 3.39 -2.63 15.27
Adjustment below Net Profit -0.04 0.00 0.03 0.02 -0.07 -0.09
P & L Balance brought forward -102.92 -105.50 -109.64 -112.62 -103.16 -118.62
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -94.72 -102.92 -105.50 -109.64 -112.62 -103.16
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.08 0.34 0.54 0.39 -1.22 2.03
Earnings Per Share(Adj)-Unit Curr 1.08 0.34 0.54 0.39 -1.22 2.03
Book Value 6.33 5.26 4.94 4.40 4.02 5.25
Book Value(Adj)-Unit Curr 6.33 5.26 4.94 4.40 4.02 5.25

Shareholding Pattern

  • Promoter Group

    31.35%

  • Public Share Holding

    68.65%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 23,672,146 30.89 23,672,146 22
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 349,346 0.46 349,346 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 24,021,492 31.35 24,021,492 26
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,712 0.00 1,292 13
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 291,037 0.38 291,037 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,700 0.00 0 2
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 295,449 0.39 292,329 17
2] Non Institution
Bodies Corporate 2,869,750 3.74 2,749,574 489
Clearing Members 403,663 0.53 403,663 28
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,461,458 1.91 1,311,426 608
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,852,936 2.42 1,841,916 894
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 12,830,889 16.74 12,830,889 171
Individuals holding nominal share capital up to Rs. 1 lakh 31,665,131 41.32 19,625,060 167,393
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 140 0.00 140 2
Others 1,232,388 1.61 1,232,388 2
Sub Total 52,316,355 68.27 39,995,056 169,587
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 76,633,296 100.00 64,308,877 169,630

Company Background

Ambalal Sarabhai Enterprises LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Ambalal Sarabhai Enterprises Ltd
  • BSE Code : 14.0
  • ISIN : INE432A01017

  • Incorporation Year

    1977

  • Registered Office

    Shanti Sadan
    Mirzapur Road, Ahmedabad,
    Gujarat-380001

  • Telephone

    91-79-25507671/25507073

  • FAX

    91-79-25507483

  • Chairman

    Kartikeya V Sarabhai

  • Managing Director

    Mohal Kartikeya Sarabhai

  • Company Secretary

    Disha Mahesh Punjani

  • Auditor

    Sorab S Engineer & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    MCS Limited
    Neelam Apt 88,
    Sampat Rao Colony,Po Race Course
    Mumbai - Vadodara 390007

Ambalal Sarabhai Enterprises Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Novartis India 1,018.80 398.23 356.27 24.93 16.64
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16